Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
Journal of Endourology|September 29, 2015
Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD RegistryKae Jack Tay, Thomas J Polascik, Ahmed Elshafei, et al.
Journal of the National Cancer Institute|January 5, 2002
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasisJeffrey A Nemeth, Rafid Yousif, Michael Herzog, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genisteinYiwei Li, Mingxin Che, Sunita Bhagat, et al.
Urology|May 25, 2018
Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate CancerDeborah R Kaye, Ji Qi, Todd M Morgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasiaJ Upadhyay, B Shekarriz, J A Nemeth, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2003
Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasisMichael L Cher, Hector R Biliran, Sunita Bhagat, et al.
The Journal of Urology|October 20, 2022
The Use and Short-term Outcomes of Active Surveillance in Men With National Comprehensive Cancer Network Favorable Intermediate-risk Prostate Cancer: The Initial Michigan Urological Surgery Improvement Collaborative ExperienceRoshan Paudel, Raghav Madan, Ji Qi, et al.
The Prostate|May 12, 2023
Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillanceMichael Wang, Andrew Lange, David Perlman, et al.
Cancer Research|March 5, 2004
A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progressionCarolyn V Ustach, Marcus E Taube, Newton J Hurst, et al.
Stem Cells (Dayton, Ohio)|April 12, 2008
Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cellsDejuan Kong, Zhiwei Wang, Sarah H Sarkar, et al.
Pageof 16